X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Watch: Biomarkers in drug development with Dr. Bernie Zeiher

By Andrew Powaleny  |    February 14, 2017
Biomarkers are powerful tools which are used by medical professionals in many ways, including in the diagnosis of disease, monitoring how a disease is progressing and, if a treatment is given, how...   Read More

The Science of Hope: Understanding biomarkers

By Andrew Powaleny  |    May 18, 2016
In the age of personalized medicine, biomarkers (short for “biological markers”) are emerging as important tools in drug development. A biomarker is a measure or physical sign that can be used to...   Read More

Lessons learned: Clinical trials

By Andrew Powaleny  |    May 9, 2016
A dynamic and collaborative health care ecosystem is crucial to conducting efficient and effective clinical trials, but two-thirds of trials fail to enroll enough participants. Misconceptions and...   Read More

Clinical Trials Q&A: A patient’s perspective

By Jocelyn Ulrich  |    May 4, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Coming soon: Clinical Trials Awareness Week, May 2-6

By Andrew Powaleny  |    April 28, 2016
Clinical trials are the most effective way to find new, innovative treatments for illnesses patients may face. But misconceptions and lack of awareness about this important research often keep...   Read More

Clinical Trials Q&A: Examining clinical trial design

By Jocelyn Ulrich  |    April 12, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    March 18, 2016
ICYMI: Policy solutions for innovative treatment: Last week at our 2016 Annual Meeting, our president and CEO Steve Ubl discussed his vision for the organization and outlined policy solutions for...   Read More

Clinical Trials Q&A: Income disparities

By Jocelyn Ulrich  |    March 14, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

ICYMI: American Society for Clinical Oncology statement on clinical pathways

By Kelsey Lang  |    January 18, 2016
Last week, the American Society for Clinical Oncology (ASCO) issued a policy statement calling for improvements in clinical pathway programs. The statement responds to the growing concern that...   Read More

New Video: Clinical trials serve as engine for local economic growth

By Priscilla VanderVeer  |    November 18, 2015
Without clinical trials, new medicines could not be approved and made available to the patients who need them. But beyond connecting patients to new treatments and potential cures for some of the...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates